131 related articles for article (PubMed ID: 6169531)
1. Ferritin - another tumor marker for testicular malignancies.
Engelmann U; Büber V; Riedmiller H; Jacobi GH
Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors.
Szymendera JJ; Kozłowicz-Gudzinska I; Madej G; Sikorowa L; Kaminska JA; Kowalska M
Oncology; 1985; 42(4):253-8. PubMed ID: 2409496
[TBL] [Abstract][Full Text] [Related]
3. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
4. [Significance of serum ferritin level in testicular tumors].
Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous measurement of tumor cytosol and peripheral serum levels of human chorionic gonadotropin and alphafetoprotein in testicular cancer.
Javadpour N; Woltering E; Soares T
Invest Urol; 1980 Jul; 18(1):11-2. PubMed ID: 6157650
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of ferritin immunostaining in testicular tumors].
Takai K; Kojima H; Kume H; Yoshimura M; Kitagawa M; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):363-8. PubMed ID: 1716406
[TBL] [Abstract][Full Text] [Related]
9. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
[TBL] [Abstract][Full Text] [Related]
11. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
12. [Staging of testicular cancer by ultrasound and tumor markers with special respect to stage I and IIA].
Behrendt H; Heckemann R; Meyer-Schwickerath M; Hartung R
Urol Int; 1983; 38(5):279-84. PubMed ID: 6195792
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
15. [Significance of tumor markers in the diagnosis and follow-up of therapeutic effects in testicular tumors].
Farkas L; Frang D; Csövári M; Pacsa S; Székely J
Orv Hetil; 1984 Jul; 125(29):1747-51. PubMed ID: 6205348
[No Abstract] [Full Text] [Related]
16. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
Javadpour N; Soares T
Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
[TBL] [Abstract][Full Text] [Related]
17. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
de Bruijn HW; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Marrink J; Ockhuizen T
Cancer; 1985 Feb; 55(4):829-35. PubMed ID: 2578303
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pregnancy-specific beta 1-glycoprotein in patients with non-seminomatous testicular germ cell tumors.
de Bruijn HW; Suurmeijer AJ; Sleijfer DT; Koops HS; Ockhuizen T; Willemse PH; Marrink J
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):911-6. PubMed ID: 6186495
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]